Objectives There are few data on ART failure rates and drug resistance from Tanzania,
where there is a wide diversity of non-B HIV subtypes. We assessed rates and predictors of …

Objectives The aim of this study was to describe clinical and virological outcomes in therapy-
naive HIV-1-positive patients treated in a routine ART programme in rural Cameroon …

Background More than 15 million people in sub-Saharan Africa receive ART. Treatment
failure is common, but the role of HIV drug resistance in treatment failure is largely unknown …

Objectives Limited availability of viral load (VL) monitoring in HIV treatment programmes in
sub-Saharan Africa can delay switching to second-line ART, leading to the accumulation of …

Introduction: Monitoring resistance to first line Antiretroviral therapy (ART) is crucial in
preventing accumulation of viral mutations following the implementation of the World Health …

Objectives: To assess viral suppression rates, to assess prevalence of acquired HIV drug
resistance and to characterize the spectrum of HIV-1 drug resistance mutations (HIV-DRM) …

Abstract In this study we report the prevalence of antiretroviral drug resistant HIV-1
genotypes of virus isolated from Djiboutian patients who failed first-line antiretroviral therapy …

Treatment outcomes of HIV patients receiving antiretroviral therapy (ART) in Rwanda are
scarcely documented. HIV viral load (VL) and HIV drug-resistance (HIVDR) outcomes at …

Background The ongoing scale-up of antiretroviral therapy (ART) in sub-Saharan Africa has
prompted the interest in surveillance of transmitted and acquired HIV drug resistance …

Objectives Emerging resistance to antiretroviral drugs may jeopardize the achievements of
improved access to ART. We compared the prevalence of different resistance mutations in …